促炎细胞因子与卒中后抑郁:讨论与思考
Pro-Inflammatory Cytokines and Post-Stroke Depression: Discussion and Thought
摘要: 脑卒中后抑郁症是脑卒中后最常见的精神疾病之一,属于创伤后应激障碍,是一种以持续情绪低落、兴趣下降为特征的心境障碍。它可能对患者生活的不同领域产生或大或小的负面影响。炎症作为机体生长发育和疾病进展中不可缺少的一部分,在脑卒中后抑郁中也起着重要作用,全身性炎症导致脑卒中风险增加和脑卒中后预后不良,这已被许多学者证实。当然,在炎症反应过程中有促炎细胞因子和炎性细胞因子的参与,促炎细胞因子可以帮助激活多种类型的免疫细胞,促进炎症的发生和发展,它们与抑郁症的病因密切相关,如果与其他诱发因素结合,反应会导致炎症过程延长,长期各轴不平衡,导致压力、疼痛、情绪变化,进而加重焦虑和抑郁。抑郁症的病理生理机制复杂多样,脑卒中后抑郁的机制尚未阐明,本文探讨促炎细胞因子与脑卒中后抑郁的关系,希望进一步解释脑卒中后抑郁的机制。
Abstract: Post-stroke depression is one of the most common mental illnesses after stroke, which belongs to post-traumatic stress disorder, and is a mood disorder characterized by persistent low mood and decreased interest. It can have a negative impact, large or small, on different areas of the patient’s life. As an indispensable part of the body’s growth and development and the progression of the dis-ease, inflammation also plays an important role in post-stroke depression, and systemic inflamma-tion leads to an increased risk of stroke and poor prognosis after stroke, which has been confirmed by many scholars. Of course, in the inflammatory response process has the participation of pro-inflammatory cytokines and inflammatory cytokines, pro-inflammatory cytokines can help ac-tivate a variety of types of immune cells to promote the occurrence and development of inflamma-tion, they are very closely related to the cause of depression, if combined with other predisposing factors, the response will lead to prolonged inflammatory processes, long-term imbalance of various axes, resulting in stress, pain, mood changes, and then aggravate anxiety and depression. The pathophysiological mechanism of depression is complex and diverse, and the mechanism of post-stroke depression has not yet been elucidated, this article discusses the relationship between pro-inflammatory cytokines and post-stroke depression, hoping to further explain the mechanism of post-stroke depression.
文章引用:胡顺鑫, 冯雷, 杨中弘. 促炎细胞因子与卒中后抑郁:讨论与思考[J]. 临床医学进展, 2024, 14(1): 2197-2210. https://doi.org/10.12677/ACM.2024.141309

参考文献

[1] Malhi, G.S. and Mann, J.J. (2018) Depression. The Lancet, 392, 2299-2312. https://linkinghub.elsevier.com/retrieve/pii/S0140673618319482 [Google Scholar] [CrossRef
[2] Sacco, R.L., Kasner, S.E., Broderick, J.P., et al. (2013) An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 44, 2064-2089.
https://www.ahajournals.org/doi/10.1161/STR.0b013e318296aeca
[3] Wang, W., Jiang, B., Sun, H., et al. (2017) Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480,687 Adults. Circulation, 135, 759-771. [Google Scholar] [CrossRef
[4] Ayerbe, L., Ayis, S., Rudd, A.G., et al. (2011) Natural History, Predictors, and Associations of Depression 5 Years after Stroke: The South London Stroke Register. Stroke, 42, 1907-1911. https://www.ahajournals.org/doi/10.1161/STROKEAHA.110.605808 [Google Scholar] [CrossRef
[5] Mitchell, A.J., Sheth, B., Gill, J., et al. (2017) Prevalence and Predictors of Post-Stroke Mood Disorders: A Meta-Analysis and Meta-Regression of Depression, Anxiety and Ad-justment Disorder. General Hospital Psychiatry, 47, 48-60. https://linkinghub.elsevier.com/retrieve/pii/S0163834317301433 [Google Scholar] [CrossRef] [PubMed]
[6] Suhett, L.G., Hermsdorff, H.H.M., Cota, B.C., et al. (2021) Dietary Inflammatory Potential, Cardiometabolic Risk and Inflammation in Children and Adolescents: A System-atic Review. Critical Reviews in Food Science and Nutrition, 61, 407-416. https://www.tandfonline.com/doi/full/10.1080/10408398.2020.1734911 [Google Scholar] [CrossRef] [PubMed]
[7] Vetrani, C., Di Nisio, A., Paschou, S.A., et al. (2022) From Gut Microbiota through Low-Grade Inflammation to Obesity: Key Players and Potential Targets. Nutrients, 14, Article 2103. https://www.mdpi.com/2072-6643/14/10/2103 [Google Scholar] [CrossRef] [PubMed]
[8] Zheng, D., Liwinski, T. and Elinav, E. (2020) Interaction between Micro-biota and Immunity in Health and Disease. Cell Research, 30, 492-506. https://www.nature.com/articles/s41422-020-0332-7 [Google Scholar] [CrossRef] [PubMed]
[9] Bagheri, S., Zolghadri, S. and Stanek, A. (2022) Beneficial Effects of Anti-Inflammatory Diet in Modulating Gut Microbiota and Controlling Obesity. Nutrients, 14, Article 3985. https://www.mdpi.com/2072-6643/14/19/3985 [Google Scholar] [CrossRef] [PubMed]
[10] Naik, S. and Fuchs, E. (2022) Inflammatory Memory and Tissue Adapta-tion in Sickness and in Health. Nature, 607, 249-255. https://www.nature.com/articles/s41586-022-04919-3 [Google Scholar] [CrossRef] [PubMed]
[11] Leslie, M. (2015) Inflammation’s Stop Signals. Science, 347, 18-21.
https://www.science.org/doi/10.1126/science.347.6217.18
[12] Levada, O.A. and Troyan, A.S. (2018) Post-stroke Depression Biomarkers: A Narrative Review. Frontiers in Neurology, 9, Article 577. https://www.frontiersin.org/article/10.3389/fneur.2018.00577/full [Google Scholar] [CrossRef] [PubMed]
[13] Busl, K.M. and Greer, D.M. (2010) Hypoxic-Ischemic Brain Injury: Pathophysiology, Neuropathology and Mechanisms. NeuroRehabilitation, 26, 5-13. https://www.medra.org/servlet/aliasResolver?alias=iospress&doi=10.3233/NRE-2010-0531 [Google Scholar] [CrossRef
[14] Shi, Q., Li, S., Lyu, Q., et al. (2023) Hypoxia Inhibits Cell Cycle Progression and Cell Proliferation in Brain Microvascular Endothelial Cells via the MiR-212-3p/MCM2 Axis. International Journal of Molecular Sciences, 24, Article 2788. https://www.mdpi.com/1422-0067/24/3/2788 [Google Scholar] [CrossRef] [PubMed]
[15] Manukjan, N., Majcher, D., Leenders, P., et al. (2023) Hypoxic Oli-godendrocyte Precursor Cell-Derived VEGFA Is Associated with Blood-Brain Barrier Impairment. Acta Neuropatho-logica Communications, 11, Article No. 128. https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-023-01627-5 [Google Scholar] [CrossRef] [PubMed]
[16] Peeples, E.S. and Genaro-Mattos, T.C. (2022) Ferroptosis: A Promising Therapeutic Target for Neonatal Hypoxic-Ischemic Brain Injury. International Journal of Molecular Sciences, 23, Article 7420. https://www.mdpi.com/1422-0067/23/13/7420 [Google Scholar] [CrossRef] [PubMed]
[17] Pivonkova, H. and Anderova, M. (2018) Altered Homeostatic Func-tions in Reactive Astrocytes and Their Potential as a Therapeutic Target after Brain Ischemic Injury. Current Pharmaceu-tical Design, 23, 5056-5074. http://www.eurekaselect.com/154077/article [Google Scholar] [CrossRef] [PubMed]
[18] Verma, R., Cronin, C.G., Hudobenko, J., et al. (2017) Deletion of the P2X4 Receptor Is Neuroprotective Acutely, but Induces a Depressive Phenotype during Recovery from Ischemic Stroke. Brain, Behavior, and Immunity, 66, 302-312. https://linkinghub.elsevier.com/retrieve/pii/S0889159117303847 [Google Scholar] [CrossRef] [PubMed]
[19] Miró-Mur, F., Pérez-De-Puig, I., Ferrer-Ferrer, M., et al. (2016) Immature Monocytes Recruited to the Ischemic Mouse Brain Differentiate into Macrophages with Features of Alternative Activation. Brain, Behavior, and Immunity, 53, 18-33. https://linkinghub.elsevier.com/retrieve/pii/S0889159115004341 [Google Scholar] [CrossRef] [PubMed]
[20] Wattananit, S., Tornero, D., Graubardt, N., et al. (2016) Mono-cyte-Derived Macrophages Contribute to Spontaneous Long-Term Functional Recovery after Stroke in Mice. The Jour-nal of Neuroscience, 36, 4182-4195. https://www.jneurosci.org/lookup/doi/10.1523/JNEUROSCI.4317-15.2016 [Google Scholar] [CrossRef
[21] Aronowski, J. and Zhao, X. (2011) Molecular Patho-physiology of Cerebral Hemorrhage: Secondary Brain Injury. Stroke, 42, 1781-1786. https://www.ahajournals.org/doi/10.1161/STROKEAHA.110.596718 [Google Scholar] [CrossRef
[22] Chen, S., Yang, Q., Chen, G., et al. (2015) An Update on Inflammation in the Acute Phase of Intracerebral Hemorrhage. Translational Stroke Research, 6, 4-8. http://link.springer.com/10.1007/s12975-014-0384-4 [Google Scholar] [CrossRef] [PubMed]
[23] Xi, G. and Keep, R.F. (2012) Intracerebral Hemorrhage: Mecha-nisms and Therapies. Translational Stroke Research, 3, 1-3. http://link.springer.com/10.1007/s12975-012-0189-2 [Google Scholar] [CrossRef] [PubMed]
[24] Xue, M. and Yong, V.W. (2020) Neuroinflammation in Intracere-bral Haemorrhage: Immunotherapies with Potential for Translation. The Lancet Neurology, 19, 1023-1032. https://linkinghub.elsevier.com/retrieve/pii/S1474442220303641 [Google Scholar] [CrossRef
[25] Zhao, X., Wu, T., Chang, C.F., et al. (2015) Toxic Role of Prostaglandin E2 Receptor EP1 after Intracerebral Hemorrhage in Mice. Brain, Behavior, and Immunity, 46, 293-310. https://linkinghub.elsevier.com/retrieve/pii/S0889159115000318 [Google Scholar] [CrossRef] [PubMed]
[26] Xiong, X.Y. and Yang, Q.W. (2015) Rethinking the Roles of In-flammation in the Intracerebral Hemorrhage. Translational Stroke Research, 6, 339-341. http://link.springer.com/10.1007/s12975-015-0402-1 [Google Scholar] [CrossRef] [PubMed]
[27] Blum, F.E. and Zuo, Z. (2013) Volatile Anesthetics-Induced Neuroinflammatory and Anti-Inflammatory Responses. Medical Gas Research, 3, Article No. 16. http://medicalgasresearch.biomedcentral.com/articles/10.1186/2045-9912-3-16 [Google Scholar] [CrossRef] [PubMed]
[28] Chen-Roetling, J., Kamalapathy, P., Cao, Y., et al. (2017) Astrocyte Heme Oxygenase-1 Reduces Mortality and Improves Outcome after Collagenase-Induced Intracerebral Hemorrhage. Neurobiology of Disease, 102, 140-146. https://linkinghub.elsevier.com/retrieve/pii/S0969996117300566 [Google Scholar] [CrossRef] [PubMed]
[29] Martins, C.A., Neves, L.T., De Oliveira, M.M.B.P., et al. (2020) Neuroprotective Effect of ACTH on Collagenase-Induced Peri-Intraventricular Hemorrhage in Newborn Male Rats. Sci-entific Reports, 10, Article No. 17734. https://www.nature.com/articles/s41598-020-74712-7 [Google Scholar] [CrossRef] [PubMed]
[30] Ayerbe, L., Ayis, S., Crichton, S.L., et al. (2014) Explanatory Factors for the Increased Mortality of Stroke Patients with Depression. Neurology, 83, 2007-2012. https://www.neurology.org/lookup/doi/10.1212/WNL.0000000000001029 [Google Scholar] [CrossRef
[31] Hackett, M.L., Yapa, C., Parag, V., et al. (2005) Frequency of Depression after Stroke: A Systematic Review of Observational Studies. Stroke, 36, 1330-1340. https://www.ahajournals.org/doi/10.1161/01.STR.0000165928.19135.35 [Google Scholar] [CrossRef
[32] Zhang, T., Jing, X., Zhao, X., et al. (2012) A Prospec-tive Cohort Study of Lesion Location and Its Relation to Post-Stroke Depression among Chinese Patients. Journal of Af-fective Disorders, 136, E83-E87. https://linkinghub.elsevier.com/retrieve/pii/S0165032711003338 [Google Scholar] [CrossRef] [PubMed]
[33] Bowden, V.M. (1992) A Reappraisal of Post-Stroke Depression, Intra- and Inter-Hemispheric Lesion Location Using Meta Analysis. JAMA: The Journal of the American Medical Asso-ciation, 268, 1473-1474. http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.1992.03490110111047 [Google Scholar] [CrossRef
[34] Starkstein, S.E., Robinson, R.G. and Price, T.R. (1987) Comparison of Cortical and Subcortical Lesions in the Production of Poststroke Mood Disorders. Brain, 110, 1045-1059. https://academic.oup.com/brain/article-lookup/doi/10.1093/brain/110.4.1045 [Google Scholar] [CrossRef] [PubMed]
[35] Yirmiya, R., Rimmerman, N. and Reshef, R. (2015) Depression as a Microglial Disease. Trends in Neurosciences, 38, 637-658. https://linkinghub.elsevier.com/retrieve/pii/S0166223615001769 [Google Scholar] [CrossRef] [PubMed]
[36] Zhuang, X., Zhan, B., Jia, Y., et al. (2022) IL-33 in the Basolateral Amygdala Integrates Neuroinflammation into Anxiogenic Circuits via Modulating BDNF Expression. Brain, Behavior, and Immunity, 102, 98-109. https://linkinghub.elsevier.com/retrieve/pii/S0889159122000484 [Google Scholar] [CrossRef] [PubMed]
[37] Maier, S.F. and Watkins, L.R. (1998) Cytokines for Psychologists: Implications of Bidirectional Immune-to-Brain Communication for Understanding Behavior, Mood, and Cognition. Psy-chological Review, 105, 83-107. [Google Scholar] [CrossRef
[38] Anrather, J. and Iadecola, C. (2016) Inflammation and Stroke: An Overview. Neurotherapeutics, 13, 661-670. http://link.springer.com/10.1007/s13311-016-0483-x [Google Scholar] [CrossRef] [PubMed]
[39] Ginhoux, F., Lim, S., Hoeffel, G., et al. (2013) Origin and Dif-ferentiation of Microglia. Frontiers in Cellular Neuroscience, 7, Article 45. http://journal.frontiersin.org/article/10.3389/fncel.2013.00045/abstract [Google Scholar] [CrossRef] [PubMed]
[40] Jenkins, S.J. and Hume, D.A. (2014) Homeostasis in the Mononu-clear Phagocyte System. Trends in Immunology, 35, 358-367. https://linkinghub.elsevier.com/retrieve/pii/S1471490614001112 [Google Scholar] [CrossRef] [PubMed]
[41] Thion, M.S., Ginhoux, F. and Garel, S. (2018) Microglia and Early Brain Development: An Intimate Journey. Science, 362, 185-189. https://www.science.org/doi/10.1126/science.aat0474 [Google Scholar] [CrossRef] [PubMed]
[42] Rodríguez-Gómez, J.A., Kavanagh, E., Engskog-Vlachos, P., et al. (2020) Microglia: Agents of the CNS Pro-Inflammatory Response. Cells, 9, Article 1717. https://www.mdpi.com/2073-4409/9/7/1717 [Google Scholar] [CrossRef] [PubMed]
[43] Harrison, N.A., Brydon, L., Walker, C., et al. (2009) Inflammation Causes Mood Changes through Alterations in Subgenual Cingulate Activity and Mesolimbic Connectivity. Biological Psychiatry, 66, 407-414. https://linkinghub.elsevier.com/retrieve/pii/S0006322309003965 [Google Scholar] [CrossRef] [PubMed]
[44] Krabbe, K.S., Reichenberg, A., Yirmiya, R., et al. (2005) Low-Dose Endotoxemia and Human Neuropsychological Functions. Brain, Behavior, and Immunity, 19, 453-460. https://linkinghub.elsevier.com/retrieve/pii/S0889159105000760 [Google Scholar] [CrossRef] [PubMed]
[45] Li, Y.C., Chou, Y.C., Chen, H.C., et al. (2019) Interleukin-6 and Interleukin-17 Are Related to Depression in Patients with Rheumatoid Arthritis. International Journal of Rheumatic Diseases, 22, 980-985. https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.13529 [Google Scholar] [CrossRef
[46] Pollak, T.A., Drndarski, S., Stone, J.M., et al. (2018) The Blood-Brain Barrier in Psychosis. The Lancet Psychiatry, 5, 79-92. [Google Scholar] [CrossRef
[47] Wohleb, E.S., Franklin, T., Iwata, M., et al. (2016) Integrat-ing Neuroimmune Systems in the Neurobiology of Depression. Nature Reviews Neuroscience, 17, 497-511. https://www.nature.com/articles/nrn.2016.69 [Google Scholar] [CrossRef] [PubMed]
[48] Wu, D., Zhang, G., Zhao, C., et al. (2020) Interleukin-18 from Neurons and Microglia Mediates Depressive Behaviors in Mice with Post-Stroke Depression. Brain, Behavior, and Immunity, 88, 411-420. https://linkinghub.elsevier.com/retrieve/pii/S0889159120301185 [Google Scholar] [CrossRef] [PubMed]
[49] Wang, Y.L., Han, Q.Q., Gong, W.Q., et al. (2018) Microglial Acti-vation Mediates Chronic Mild Stress-Induced Depressive- and Anxiety-Like Behavior in Adult Rats. Journal of Neu-roinflammation, 15, Article No. 21. https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1054-3 [Google Scholar] [CrossRef] [PubMed]
[50] Wei, L., Guo, J., Yu, X., et al. (2021) Role and Characteristics of Hippocampal Region Microglial Activation in Poststroke Depression. Journal of Affective Disorders, 291, 270-278. https://linkinghub.elsevier.com/retrieve/pii/S0165032721004663 [Google Scholar] [CrossRef] [PubMed]
[51] Alderton, G. and Scanlon, S.T. (2021) Inflammation: An Expanding View. Science, 374, 1068-1069. https://www.science.org/doi/10.1126/science.abn1721 [Google Scholar] [CrossRef] [PubMed]
[52] Calabrese, F., Rossetti, A.C., Racagni, G., et al. (2014) Brain-Derived Neurotrophic Factor: A Bridge between Inflammation and Neuroplasticity. Frontiers in Cellular Neuroscience, 8, Article No. 430. http://journal.frontiersin.org/article/10.3389/fncel.2014.00430/abstract [Google Scholar] [CrossRef] [PubMed]
[53] Xu, H.B., Xu, Y.H., He, Y., et al. (2018) Decreased Serum Brain-Derived Neurotrophic Factor May Indicate the Development of Poststroke Depression in Patients with Acute Is-chemic Stroke: A Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases, 27, 709-715. https://linkinghub.elsevier.com/retrieve/pii/S1052305717305542 [Google Scholar] [CrossRef] [PubMed]
[54] Dowlati, Y., Herrmann, N., Swardfager, W., et al. (2010) A Meta-Analysis of Cytokines in Major Depression. Biological Psychiatry, 67, 446-457. https://linkinghub.elsevier.com/retrieve/pii/S0006322309012293 [Google Scholar] [CrossRef] [PubMed]
[55] Osimo, E.F., Pillinger, T., Rodriguez, I.M., et al. (2020) In-flammatory Markers in Depression: A Meta-Analysis of Mean Differences and Variability in 5166 Patients and 5083 Controls. Brain, Behavior, and Immunity, 87, 901-909. [Google Scholar] [CrossRef] [PubMed]
[56] Schmidt-Arras, D. and Rose-John, S. (2016) IL-6 Pathway in the Liver: from Physiopathology to Therapy. Journal of Hepatology, 64, 1403-1415. https://linkinghub.elsevier.com/retrieve/pii/S0168827816000830 [Google Scholar] [CrossRef] [PubMed]
[57] Maeda, Y., Matsumoto, M., Hori, O., et al. (1994) Hypox-ia/Reoxygenation-Mediated Induction of Astrocyte Interleukin 6: A Paracrine Mechanism Potentially Enhancing Neuron Survival. Journal of Experimental Medicine, 180, 2297-2308. https://rupress.org/jem/article/180/6/2297/25664/Hypoxiareoxygenationmediated-induction-of [Google Scholar] [CrossRef] [PubMed]
[58] Acalovschi, D., Wiest, T., Hartmann, M., et al. (2003) Multiple Levels of Regulation of the Interleukin-6 System in Stroke. Stroke, 34, 1864-1869. https://www.ahajournals.org/doi/10.1161/01.STR.0000079815.38626.44 [Google Scholar] [CrossRef
[59] Leasure, A.C., Kuohn, L.R., Vanent, K.N., et al. (2021) Association of Serum IL-6 (Interleukin 6) with Functional Outcome after Intracerebral Hemorrhage. Stroke, 52, 1733-1740. https://www.ahajournals.org/doi/10.1161/STROKEAHA.120.032888 [Google Scholar] [CrossRef
[60] Kang, H.J., Bae, K.Y., Kim, S.W., et al. (2016) Effects of Interleukin-6, Interleukin-18, and Statin Use, Evaluated at Acute Stroke, on Post-Stroke Depression during 1-Year Follow-Up. Psychoneuroendocrinology, 72, 156-160. https://linkinghub.elsevier.com/retrieve/pii/S0306453016302062 [Google Scholar] [CrossRef] [PubMed]
[61] Chen, J.Y., Yu, Y., Yuan, Y., et al. (2017) Enriched Housing Promotes Post-Stroke Functional Recovery through Astrocytic HMGB1-IL-6-Mediated Angiogenesis. Cell Death Dis-covery, 3, Article 17054. https://www.nature.com/articles/cddiscovery201754 [Google Scholar] [CrossRef] [PubMed]
[62] Chen, X., Liu, L., Zhong, Y., et al. (2023) Enriched Environment Promotes Post-Stroke Angiogenesis through Astrocytic Interleukin-17A. Frontiers in Behavioral Neuroscience, 17, Ar-ticle 1053877. https://www.frontiersin.org/articles/10.3389/fnbeh.2023.1053877/full [Google Scholar] [CrossRef] [PubMed]
[63] Wu, X., Liu, S., Hu, Z., et al. (2018) Enriched Housing Promotes Post-Stroke Neurogenesis through Calpain 1-STAT3/HIF-1α/VEGF Signaling. Brain Research Bulletin, 139, 133-143. https://linkinghub.elsevier.com/retrieve/pii/S0361923017306226 [Google Scholar] [CrossRef] [PubMed]
[64] Franchi, L., Eigenbrod, T., Muñoz-Planillo, R., et al. (2009) The Inflammasome: A Caspase-1-Activation Platform That Regulates Immune Responses and Disease Pathogenesis. Nature Immunology, 10, 241-247. https://www.nature.com/articles/ni.1703 [Google Scholar] [CrossRef] [PubMed]
[65] Gabay, C., Lamacchia, C. and Palmer, G. (2010) IL-1 Pathways in Inflamma-tion and Human Diseases. Nature Reviews Rheumatology, 6, 232-241. https://www.nature.com/articles/nrrheum.2010.4 [Google Scholar] [CrossRef] [PubMed]
[66] Dinarello, C.A. (2013) Overview of the Interleukin-1 Family of Lig-ands and Receptors. Seminars in Immunology, 25, 389-393. https://linkinghub.elsevier.com/retrieve/pii/S1044532313000821 [Google Scholar] [CrossRef] [PubMed]
[67] Audet, M.C. and Anisman, H. (2013) Interplay between Pro-Inflammatory Cytokines and Growth Factors in Depressive Illnesses. Frontiers in Cellular Neuroscience, 7, Article 68. http://journal.frontiersin.org/article/10.3389/fncel.2013.00068/abstract [Google Scholar] [CrossRef] [PubMed]
[68] Smith, C.J., Hulme, S., Vail, A., et al. (2018) SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 Trial. Stroke, 49, 1210-1216. https://www.ahajournals.org/doi/10.1161/STROKEAHA.118.020750 [Google Scholar] [CrossRef
[69] Li, M., Li, C., Yu, H., et al. (2017) Lentivirus-Mediated Interleukin-1β (IL-1β) Knock-Down in the Hippocampus Alleviates Lipopolysaccharide (LPS)-Induced Memory Deficits and Anxiety- and Depression-Like Behaviors in Mice. Journal of Neuroinflammation, 14, Article No. 190. http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0964-9 [Google Scholar] [CrossRef] [PubMed]
[70] Goshen, I., Kreisel, T., Ben-Menachem-Zidon, O., et al. (2008) Brain Interleukin-1 Mediates Chronic Stress-Induced Depression in Mice via Adrenocortical Activation and Hippocampal Neurogenesis Suppression. Molecular Psychiatry, 13, 717-728. https://www.nature.com/articles/4002055 [Google Scholar] [CrossRef] [PubMed]
[71] Kurosawa, N., Shimizu, K. and Seki, K. (2016) The Development of Depression-Like Behavior Is Consolidated by IL-6-Induced Activation of Locus Coeruleus Neurons and IL-1β-Induced Elevated Leptin Levels in Mice. Psychopharmacology, 233, 1725-1737. http://link.springer.com/10.1007/s00213-015-4084-x [Google Scholar] [CrossRef] [PubMed]
[72] Ge, Y., Xu, W., Zhang, L., et al. (2020) Ginkgolide B Attenuates Myocardial Infarction-Induced Depression-Like Behaviors via Repressing IL-1β in Central Nervous System. Interna-tional Immunopharmacology, 85, Article 106652. https://linkinghub.elsevier.com/retrieve/pii/S1567576920305464 [Google Scholar] [CrossRef] [PubMed]
[73] Jang, S.E., Lim, S.M., Jeong, J.J., et al. (2018) Gastrointestinal Inflammation by Gut Microbiota Disturbance Induces Memory Impairment in Mice. Mucosal Immunology, 11, 369-379. https://linkinghub.elsevier.com/retrieve/pii/S1933021922005153 [Google Scholar] [CrossRef] [PubMed]
[74] Lee, D.Y., Shin, Y.J., Kim, J.K., et al. (2021) Alleviation of Cognitive Impairment by Gut Microbiota Lipopolysaccharide Production-Suppressing Lactobacillus plantarum and Bifidobacte-rium Longum in Mice. Food & Function, 12, 10750-10763. http://xlink.rsc.org/?DOI=D1FO02167B [Google Scholar] [CrossRef
[75] Yun, S.W., Park, H.S., Shin, Y.J., et al. (2023) Lactobacillus gasseri NK109 and Its Supplement Alleviate Cognitive Impairment in Mice by Modulating NF-κB Activation, BDNF Expres-sion, and Gut Microbiota Composition. Nutrients, 15, Article 790. https://www.mdpi.com/2072-6643/15/3/790 [Google Scholar] [CrossRef] [PubMed]
[76] Aggarwal, B.B., Gupta, S.C. and Kim, J.H. (2012) Historical Perspec-tives on Tumor Necrosis Factor and Its Superfamily: 25 Years Later, a Golden Journey. Blood, 119, 651-665. https://ashpublications.org/blood/article/119/3/651/135109/Historical-perspectives-on-tumor-necrosis-factor [Google Scholar] [CrossRef] [PubMed]
[77] Maddahi, A., Kruse, L.S., Chen, Q.W., et al. (2011) The Role of Tumor Necrosis Factor-α and TNF-α Receptors in Cerebral Arteries Following Cerebral Ischemia in Rat. Journal of Neuroinflammation, 8, Article No. 107. [Google Scholar] [CrossRef] [PubMed]
[78] Kriz, J. and Lalancette-Hébert, M. (2009) Inflammation, Plasticity and Real-Time Imaging after Cerebral Ischemia. Acta Neuropathologica, 117, 497-509. http://link.springer.com/10.1007/s00401-009-0496-1 [Google Scholar] [CrossRef] [PubMed]
[79] Chen, A.Q., Fang, Z., Chen, X.L., et al. (2019) Microglia-Derived TNF-α Mediates Endothelial Necroptosis Aggravating Blood Brain-Barrier Disruption after Ischemic Stroke. Cell Death & Disease, 10, Article No. 487. https://www.nature.com/articles/s41419-019-1716-9 [Google Scholar] [CrossRef] [PubMed]
[80] Doll, D.N., Rellick, S.L., Barr, T.L., et al. (2015) Rapid Mito-chondrial Dysfunction Mediates TNF-Alpha-Induced Neurotoxicity. Journal of Neurochemistry, 132, 443-451. https://onlinelibrary.wiley.com/doi/10.1111/jnc.13008 [Google Scholar] [CrossRef] [PubMed]
[81] Lima Giacobbo, B., Doorduin, J., Klein, H.C., et al. (2019) Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation. Molecular Neurobiology, 56, 3295-3312. http://link.springer.com/10.1007/s12035-018-1283-6 [Google Scholar] [CrossRef] [PubMed]
[82] Bramham, C.R. and Messaoudi, E. (2005) BDNF Function in Adult Synaptic Plasticity: The Synaptic Consolidation Hypothesis. Progress in Neurobiology, 76, 99-125. [Google Scholar] [CrossRef] [PubMed]
[83] Mizui, T., Ishikawa, Y., Kumanogoh, H., et al. (2016) Neu-robiological Actions by Three Distinct Subtypes of Brain-Derived Neurotrophic Factor: Multi-Ligand Model of Growth Factor Signaling. Pharmacological Research, 105, 93-98. https://linkinghub.elsevier.com/retrieve/pii/S1043661815302589 [Google Scholar] [CrossRef] [PubMed]
[84] Duman, R.S. and Aghajanian, G.K. (2012) Synaptic Dysfunction in Depression: Potential Therapeutic Targets. Science, 338, 68-72. https://www.science.org/doi/10.1126/science.1222939 [Google Scholar] [CrossRef] [PubMed]
[85] Khan, M.S., Wu, G.W.Y., Reus, V.I., et al. (2019) Low Serum Brain-Derived Neurotrophic Factor Is Associated with Suicidal Ideation in Major Depressive Disorder. Psychiatry Re-search, 273, 108-113. https://linkinghub.elsevier.com/retrieve/pii/S0165178118319668 [Google Scholar] [CrossRef] [PubMed]
[86] Molendijk, M.L., Bus, B.A.A., Spinhoven, P., et al. (2011) Serum Levels of Brain-Derived Neurotrophic Factor in Major Depressive Disorder: State-Trait Issues, Clinical Features and Pharmacological Treatment. Molecular Psychiatry, 16, 1088-1095. https://www.nature.com/articles/mp201098 [Google Scholar] [CrossRef] [PubMed]
[87] Sheldrick, A., Camara, S., Ilieva, M., et al. (2017) Brain-Derived Neu-rotrophic Factor (BDNF) and Neurotrophin 3 (NT3) Levels in Post-Mortem Brain Tissue from Patients with Depression Compared to Healthy Individuals—A Proof of Concept Study. European Psychiatry, 46, 65-71. https://www.cambridge.org/core/product/identifier/S0924933800068541/type/journal_article [Google Scholar] [CrossRef] [PubMed]
[88] Zhou, Z., Lu, T., Xu, G., et al. (2011) Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Is Associated with Post-Stroke De-pression but Not with BDNF Gene Val66Met Polymorphism. Clinical Chemistry and Laboratory Medicine, 49, 185-189. https://www.degruyter.com/document/doi/10.1515/CCLM.2011.039/html [Google Scholar] [CrossRef
[89] Kim, Y.K., Na, K.S., Shin, K.H., et al. (2007) Cytokine Imbalance in the Pathophysiology of Major Depressive Disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31, 1044-1053. https://linkinghub.elsevier.com/retrieve/pii/S027858460700098X [Google Scholar] [CrossRef] [PubMed]
[90] Schnydrig, S., Korner, L., Landweer, S., et al. (2007) Peripheral Lipopolysaccharide Administration Transiently Affects Expression of Brain-Derived Neurotrophic Factor, Corticotropin and Proopiomelanocortin in Mouse Brain. Neuroscience Letters, 429, 69-73. https://linkinghub.elsevier.com/retrieve/pii/S0304394007010762 [Google Scholar] [CrossRef] [PubMed]
[91] Lai, N.S., Yu, H.C., Huang Tseng, H.Y., et al. (2021) Increased Serum Levels of Brain-Derived Neurotrophic Factor Contribute to Inflammatory Responses in Patients with Rheumatoid Arthritis. International Journal of Molecular Sciences, 22, Article 1841. https://www.mdpi.com/1422-0067/22/4/1841 [Google Scholar] [CrossRef] [PubMed]
[92] Tao, W., Zhang, X., Ding, J., et al. (2022) The Effect of Propofol on Hypoxia- and TNF-α-Mediated BDNF/TrkB Pathway Dysregulation in Primary Rat Hippocampal Neurons. CNS Neu-roscience & Therapeutics, 28, 761-774. https://onlinelibrary.wiley.com/doi/10.1111/cns.13809 [Google Scholar] [CrossRef] [PubMed]
[93] Yu, H.C., Huang, H.B., Huang Tseng, H.Y., et al. (2022) Brain-Derived Neurotrophic Factor Suppressed Proinflammatory Cytokines Secretion and Enhanced MicroRNA(MiR)-3168 Expres-sion in Macrophages. International Journal of Molecular Sciences, 23, Article 570. https://www.mdpi.com/1422-0067/23/1/570 [Google Scholar] [CrossRef] [PubMed]
[94] Barer, D. (2010) A Brief Psychosocial-Behavioral Intervention Reduced Depression after Stroke More than Usual Care. Annals of Internal Medicine, 152, JC3. http://annals.org/article.aspx?doi=10.7326/0003-4819-152-6-201003160-02010 [Google Scholar] [CrossRef] [PubMed]
[95] Mitchell, P.H., Veith, R.C., Beck-er, K.J., et al. (2009) Brief Psychosocial-Behavioral Intervention with Antidepressant Reduces Poststroke Depression Significantly More than Usual Care with Antidepressant: Living Well with Stroke: Randomized, Controlled Trial. Stroke, 40, 3073-3078. https://www.ahajournals.org/doi/10.1161/STROKEAHA.109.549808 [Google Scholar] [CrossRef
[96] Gao, Z., Wang, Y. and Yu, H. (2022) A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview. Me-dicina, 59, Article 55. https://www.mdpi.com/1648-9144/59/1/55 [Google Scholar] [CrossRef] [PubMed]
[97] Kwon, C.Y., Lee, B., Chung, S.Y., et al. (2019) Efficacy and Safety of Sihogayonggolmoryeo-Tang (Saikokaryukotsuboreito, Chai-Hu-Jia-Long-Gu-Mu-Li-Tang) for Post-Stroke Depression: A Systematic Review and Meta-Analysis. Scientific Reports, 9, Article No. 14536. https://www.nature.com/articles/s41598-019-51055-6 [Google Scholar] [CrossRef] [PubMed]
[98] Wu, T., Yue, T., Yang, P., et al. (2022) Notable Efficacy of Shugan Jieyu Capsule in Treating Adult with Post-Stroke Depression: A PRISMA-Compliant Meta-Analysis of Ran-domized Controlled Trials. Journal of Ethnopharmacology, 294, Article 115367. https://linkinghub.elsevier.com/retrieve/pii/S0378874122004068 [Google Scholar] [CrossRef] [PubMed]